Meridian Bioscience Profit Margin 2006-2019 | VIVO

Current and historical gross margin, operating margin and net profit margin for Meridian Bioscience (VIVO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Meridian Bioscience net profit margin as of September 30, 2019 is 12.13%.
Meridian Bioscience Annual Profit Margins
Meridian Bioscience Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.396B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $151.583B 20.94
Abbott Laboratories (ABT) United States $151.168B 27.57
Stryker (SYK) United States $76.313B 25.66
Boston Scientific (BSX) United States $61.440B 29.00
Baxter (BAX) United States $42.463B 25.75
Essilor Luxottica (ESLOY) France $33.468B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.550B 19.17
Terumo (TRUMY) Japan $27.062B 0.00
Lonza Group Ag (LZAGY) Switzerland $25.531B 0.00
Coloplast (CLPBY) Denmark $25.294B 39.03
ResMed (RMD) United States $21.653B 39.94
Smith & Nephew SNATS (SNN) United Kingdom $19.279B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.373B 541.06
Bio-Rad Laboratories (BIO) United States $11.201B 53.76
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Hill-Rom Holdings (HRC) United States $7.203B 21.24
Perrigo (PRGO) Ireland $7.117B 13.27
Canopy Growth (CGC) Canada $6.501B 0.00
Haemonetics (HAE) United States $6.146B 41.53
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 0.00
NuVasive (NUVA) United States $3.890B 30.64
ICU Medical (ICUI) United States $3.830B 24.97
Neogen (NEOG) United States $3.545B 59.33
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.165B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.121B 0.00
Quidel (QDEL) United States $2.954B 28.04
Aurora Cannabis (ACB) Canada $2.648B 0.00
National Vision Holdings (EYE) United States $2.432B 54.89
Agios Pharmaceuticals (AGIO) United States $2.411B 0.00
Cardiovascular Systems (CSII) United States $1.577B 0.00
InMode (INMD) Israel $1.516B 0.00
AtriCure (ATRC) United States $1.226B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.162B 23.28
Phibro Animal Health (PAHC) United States $0.994B 18.61
NanoString Technologies (NSTG) United States $0.944B 0.00
Lantheus Holdings (LNTH) United States $0.802B 20.04
Eagle Pharmaceuticals (EGRX) United States $0.771B 29.55
TG Therapeutics (TGTX) United States $0.709B 0.00
Quanterix (QTRX) United States $0.705B 0.00
LeMaitre Vascular (LMAT) United States $0.698B 39.25
PetIQ (PETQ) United States $0.675B 16.46
Omeros (OMER) United States $0.655B 0.00
Cerus (CERS) United States $0.574B 0.00
Surmodics (SRDX) United States $0.570B 59.24
HEXO (HEXO) $0.537B 0.00
OraSure Technologies (OSUR) United States $0.492B 29.52
Owens & Minor (OMI) United States $0.474B 17.53
MacroGenics (MGNX) United States $0.474B 0.00
Organigram Holdings (OGI) Canada $0.405B 0.00
Utah Medical Products (UTMD) United States $0.396B 28.71
BioLife Solutions (BLFS) United States $0.331B 134.92
Zynex (ZYXI) United States $0.329B 37.22
Bovie Medical (APYX) United States $0.275B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.269B 0.00
United Health Products (UEEC) United States $0.249B 0.00
Viemed Healthcare (VMD) United States $0.242B 25.52
Vapotherm (VAPO) United States $0.227B 0.00
Repro-Med Systems (KRMD) United States $0.195B 0.00
Liberty Health Sciences (LHSIF) Canada $0.192B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Chimerix (CMRX) United States $0.151B 0.00
Female Health (VERU) United States $0.148B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
Cytosorbents (CTSO) United States $0.128B 0.00
Fonar (FONR) United States $0.128B 9.03
MTech Acquisition (KERN) United States $0.114B 0.00
United-Guardian (UG) United States $0.091B 23.15
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
Nephros (NEPH) United States $0.064B 0.00
Surface Oncology (SURF) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00